Related references
Note: Only part of the references are listed.Prognostic Implications of Immunohistochemical Biomarkers in Non-muscle-invasive Blad Cancer and Muscle-invasive Bladder Cancer
Martin Boegemann et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)
Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Alex Pearson et al.
CLINICAL CANCER RESEARCH (2020)
Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis
Katarzyna A. Roszkowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Targeting transcription factors in cancer - from undruggable to reality
John H. Bushweller
NATURE REVIEWS CANCER (2019)
Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection
Ellen Wallace et al.
JOURNAL OF UROLOGY (2018)
Tandem repeats mediating genetic plasticity in health and disease
Anthony J. Hannan
NATURE REVIEWS GENETICS (2018)
Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance
Renate Pichler et al.
BJU INTERNATIONAL (2018)
FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer
Shucai Yang et al.
MOLECULAR CANCER (2017)
CCAAT enhancer binding protein β has a crucial role in regulating breast cancer cell growth via activating the TGF-β-Smad3 signaling pathway
Jing Cao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice Andre et al.
CANCER DISCOVERY (2017)
Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes
Sami Benzina et al.
ONCOTARGET (2017)
Characterization of VNTRs Within the Entire Region of SLC6A3 and Its Association with Hypertension
Won-Tae Kim et al.
DNA AND CELL BIOLOGY (2017)
Dual transcripts of BCR-ABL & different polymorphisms in chronic myeloid leukaemia patients
S. Rajashree Nandagopalan et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2016)
Depression accelerates the development of gastric cancer through reactive oxygen species-activated ABL1 (Review)
Tianhe Huang et al.
ONCOLOGY REPORTS (2016)
Update on the management of non-muscle invasive bladder cancer
Saad Aldousari et al.
CUAJ-Canadian Urological Association Journal (2016)
The Philadelphia chromosome in leukemogenesis
Zhi-Jie Kang et al.
CHINESE JOURNAL OF CANCER (2016)
Tandem repeat variation in human and great ape populations and its impact on gene expression divergence
Tugce Bilgin Sonay et al.
GENOME RESEARCH (2015)
Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing
Jana Linhartova et al.
Molecular Cancer (2015)
The Emerging Role of ABL Kinases in Solid Tumors
Jun Wang et al.
TRENDS IN CANCER (2015)
Reduced Glucocorticoid Receptor Expression Predicts Bladder Tumor Recurrence and Progression
Hitoshi Ishiguro et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
The Capable ABL: What Is Its Biological Function?
Jean Y. J. Wang
MOLECULAR AND CELLULAR BIOLOGY (2014)
Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo
H. Gil-Henn et al.
ONCOGENE (2013)
Testing association with Fisher's Exact test
Pamela Warner
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE (2013)
Role of ABL family kinases in cancer: from leukaemia to solid tumours
Emileigh K. Greuber et al.
NATURE REVIEWS CANCER (2013)
Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia
Manuela Krumbholz et al.
GENES CHROMOSOMES & CANCER (2012)
Susceptibility for breast cancer in young patients with short rare minisatellite alleles of BORIS
Se-Lyun Yoon et al.
BMB Reports (2011)
Multifunctional transcription factor TFII-I is an activator of BRCA1 function
M. Tanikawa et al.
BRITISH JOURNAL OF CANCER (2011)
Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias
Thomas Burmeister et al.
DNA REPAIR (2011)
Detection of DNA fusion junctions for BCR-ABL translocations by Anchored ChromPET
Yoshiyuki Shibata et al.
GENOME MEDICINE (2010)
Molecular biology of bcr-abl1-positive chronic myeloid leukemia
Alfonso Quintas-Cardama et al.
BLOOD (2009)
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription
Rajani Kanteti et al.
LABORATORY INVESTIGATION (2009)
Emerging Roles of the EBF Family of Transcription Factors in Tumor Suppression
Daiqing Liao
MOLECULAR CANCER RESEARCH (2009)
Analysis of VNTRs in the Solute Carrier Family 6, Member 18 (SLC6A18) and Lack of Association with Hypertension
Young-Ho Yoon et al.
DNA AND CELL BIOLOGY (2008)
Identification and structural comparison of deleterious mutations in nsSNPs of ABL1 gene in chronic myeloid leukemia: A bio-informatics study
C. George Priya Doss et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2008)
Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival
D. Srinivasan et al.
ONCOGENE (2008)
Rare Exonic Minisatellite Alleles in MUC2 Influence Susceptibility to Gastric Carcinoma
Yun Hee Jeong et al.
PLOS ONE (2007)
Clustal W and clustal X version 2.0
M. A. Larkin et al.
BIOINFORMATICS (2007)
Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells
Divyamani Srinivasan et al.
CANCER RESEARCH (2006)
Bladder cancer: Epidemiology, staging and grading, and diagnosis
Z Kirkali et al.
UROLOGY (2005)
MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment
S Kumar et al.
BRIEFINGS IN BIOINFORMATICS (2004)
Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome
E Kolomietz et al.
LEUKEMIA (2003)
Nonrandom distribution of interspersed repeat elements in the BCR and ABLI genes and its relation to breakpoint cluster regions
AR Jeffs et al.
GENES CHROMOSOMES & CANCER (2001)
Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest
M Simoneau et al.
ONCOGENE (2000)
Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia
PB Sinclair et al.
BLOOD (2000)
Share Paper
